These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18400823)

  • 1. Lack of elevation of urinary albumin excretion among patients with chronic syndromes of inappropriate antidiuresis.
    Vandergheynst F; Decaux G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2399-401. PubMed ID: 18400823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
    Vandergheynst F; Pradier O; Beukinga I; Kornreich A; Vassart G; Decaux G
    Eur J Clin Invest; 2012 Mar; 42(3):254-9. PubMed ID: 21834801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.
    Bardoux P; Bichet DG; Martin H; Gallois Y; Marre M; Arthus MF; Lonergan M; Ruel N; Bouby N; Bankir L
    Nephrol Dial Transplant; 2003 Mar; 18(3):497-506. PubMed ID: 12584270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
    Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
    J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus].
    Radó J; Pató E
    Orv Hetil; 1983 May; 124(22):1323-6. PubMed ID: 6877810
    [No Abstract]   [Full Text] [Related]  

  • 6. Intermittent severe, symptomatic hyponatraemia due to the nephrogenic syndrome of inappropriate antidiuresis.
    Soule S; Florkowski C; Potter H; Pattison D; Swan M; Hunt P; George P
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):520-3. PubMed ID: 18753429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction.
    Rosenthal SM; Feldman BJ; Vargas GA; Gitelman SE
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():66-70. PubMed ID: 17261972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats.
    Kazama I; Arata T; Michimata M; Hatano R; Suzuki M; Miyama N; Sanada S; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
    Nephrol Dial Transplant; 2007 Jan; 22(1):68-76. PubMed ID: 16702208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
    Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance.
    Decaux G; Namias B; Gulbis B; Soupart A
    J Am Soc Nephrol; 1996 May; 7(5):805-10. PubMed ID: 8738818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year experience with DDAVP in treatment of diabetes insipidus.
    Marek J; Loutocký A; Pacovský V; Zaoral M
    Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hyponatremia due to desmopressin.
    Kelleher HB; Henderson SO
    J Emerg Med; 2006 Jan; 30(1):45-7. PubMed ID: 16434334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study.
    Johnson TM; Burridge A; Issa MM; Miller M; Tang T; Ouslander JG
    J Am Geriatr Soc; 2007 Apr; 55(4):562-9. PubMed ID: 17397435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of vasopressin analogue DDAVP in patients with postoperative diabetes insipidus (author's transl)].
    Kubota T; Kashiwara K; Ito H; Tani K; Yamamoto S
    No To Shinkei; 1981 Jun; 33(3):617-23. PubMed ID: 7259900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
    Coculescu M; Antipa C; Cucu C
    Endocrinologie; 1977; 15(4):275-81. PubMed ID: 563614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP; Marosi J; Fischer J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
    Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
    Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Insipidus and Syndrome of Inappropriate Antidiuretic Hormone in Critically Ill Patients.
    Harrois A; Anstey JR
    Crit Care Clin; 2019 Apr; 35(2):187-200. PubMed ID: 30784603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.